CDK5-mediated phosphorylation and stabilization of TPX2 promotes hepatocellular tumorigenesis

被引:0
作者
Fuqiang Wang
Wenxing Zhao
Yuehong Gao
Jiechao Zhou
Huifang Li
Guanyun Zhang
Dong Guo
Chengrong Xie
Jie Li
Zhenyu Yin
Jie Zhang
机构
[1] Zhongshan Hospital of Xiamen University,Department of Hepatobiliary Surgery
[2] Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma,Fujian Provincial Key Laboratory of Neurodegenerative Diseaseand Aging Research, Institute of Neuroscience, School of Medicine
[3] Taian City Central Hospital,Solomon H. Snyder Department of Neuroscience
[4] Xiamen University,undefined
[5] Johns Hopkins University School of Medicine,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词
Cyclin-dependent kinase 5; Hepatocellular carcinoma; Target protein for Xklp2; Tamoxifen;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 272 条
[1]  
El-Serag HB(2007)Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2557-2576
[2]  
Rudolph KL(2012)Hepatocellular carcinoma Lancet 379 1245-1255
[3]  
Forner A(2014)Sorafenib use in hepatocellular carcinoma: more questions than answers Hepatology 60 15-18
[4]  
Llovet JM(2009)Cell cycle, CDKs and cancer: a changing paradigm Nat Rev Cancer 9 153-166
[5]  
Bruix J(2009)Cell cycle kinases as therapeutic targets for cancer Nat Rev Drug Discov 8 547-566
[6]  
Abou-Alfa GK(2001)A decade of CDK5 Nat Rev Mol Cell Biol 2 749-759
[7]  
Malumbres M(2004)A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease Curr Opin Neurobiol 14 390-394
[8]  
Barbacid M(2010)Regulation and role of cyclin-dependent kinase activity in neuronal survival and death J Neurochem 115 1309-1321
[9]  
Lapenna S(2010)Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling Cancer Res 70 4460-4469
[10]  
Giordano A(2010)Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5 Nature 466 451-456